Open Access
Issue
Parasite
Volume 28, 2021
Article Number 7
Number of page(s) 7
DOI https://doi.org/10.1051/parasite/2021004
Published online 02 February 2021
  1. Akhoundi M, Sereno D, Durand R, Mirzaei A, Bruel C, Delaunay P, Marty P, Izri A. 2020. Bed Bugs (Hemiptera, Cimicidae): Overview of Classification, Evolution and Dispersion. International Journal of Environmental Research and Public Health, 17, 4576. [Google Scholar]
  2. Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. 2016. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite, 23, 26. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Beugnet F, Halos L, Larsen D, de Vos C. 2016. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite, 23, 14. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Cannet A, Akhoundi M, Berenger JM, Michel G, Marty P, Delaunay P. 2015. A review of data on laboratory colonies of bed bugs (Cimicidae), an insect of emerging medical relevance. Parasite, 22, 21. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Carithers D, Crawford J, de Vos C, Lotriet A, Fourie J. 2016. Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs. Parasites & Vectors, 9, 635. [CrossRef] [PubMed] [Google Scholar]
  6. Dang K, Doggett SL, Singham GV, Lee CY. 2017. Insecticide resistance and resistance mechanisms in bed bugs, Cimex spp. (Hemiptera: Cimicidae). Parasites & Vectors, 10, 318. [CrossRef] [PubMed] [Google Scholar]
  7. Delaunay P, Blanc V, Del Giudice P, Levy-Bencheton A, Chosidow O, Marty P, Brouqui P. 2011. Bedbugs and infectious diseases. Clinical Infectious Diseases, 52, 200–210. [CrossRef] [Google Scholar]
  8. Durand R, Cannet A, Berdjane Z, Bruel C, Haouchine D, Delaunay P, Izri A. 2012. Infestation by pyrethroids resistant bed bugs in the suburb of Paris, France. Parasite, 19, 381–387. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. European Medicine Agency Committee for Medicinal Products for Veterinary Use. 2007. Guidelines for the testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestation in dogs and cats. London: EMA Guideline No. EMEA/CVMP/EWP/005/2000-Rev2-2007. [Google Scholar]
  10. European Medicines Agency. 2014. Nexgard® summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/002729/WC500164067.pdf. [Google Scholar]
  11. European Union. 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union, 276, 33–79. [Google Scholar]
  12. Hwang SW, Svoboda TJ, De Jong IJ, Kabasele KJ, Gogosis E. 2005. Bed bug infestations in an urban environment. Emerging Infectious Diseases, 11, 533–538. [CrossRef] [PubMed] [Google Scholar]
  13. Jourdain F, Delaunay P, Bérenger JM, Perrin Y, Robert V. 2016. The Common bed bug (Cimex lectularius) in metropolitan France. Survey on the attitudes and practices of private- and public-sector professionals. Parasite, 23, 38. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Kassianoff L. 1937. Étude morphologique et biologique de la famille des Cimicidés. Annales de Parasitologie Humaine et Comparée, 15, 97–408. [CrossRef] [Google Scholar]
  15. Laino MA, Cardinal MA, Enriquez GF, Alvedro A, Gaspe MS, Gurtler RE. 2019. An oral dose of Fluralaner administered to dogs kills pyrethroid-resistant and susceptible Chagas disease vectors for at least four months. Veterinary Parasitology, 268, 98–104. [CrossRef] [PubMed] [Google Scholar]
  16. Letendre L, Huang R, Kvaternick V, Harriman J, Drag M, Soll M. 2014. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs. Veterinary Parasitology, 201, 190–197. [CrossRef] [PubMed] [Google Scholar]
  17. Liebenberg J, Fourie J, Lebon W, Larsen D, Halos L, Beugnet F. 2017. Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard®. Parasite, 24, 39. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  18. Loza A, Talaga A, Herbas G, Jair Canaviri R, Cahuasiri T, Luck L, Guibarra A, Goncalves R, Pereira JA, Gomez SA, Picado A, Messenger LA, Bern C, Courtenay O. 2017. Systemic insecticide treatment of the canine reservoir of Trypanosoma cruzi induces high levels of lethality in Triatoma infestans, a principal vector of Chagas disease. Parasites & Vectors, 10, 344. [CrossRef] [PubMed] [Google Scholar]
  19. Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, Dryden MW. 2013. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Veterinary Parasitology, 194, 84–97. [CrossRef] [PubMed] [Google Scholar]
  20. Peres G, Buonalumi Tacito Yugar L, Haddad Junior V. 2018. Breakfast, lunch, and dinner sign: a hallmark of flea and bedbug bites. Anais Brasileiros de Dermatologia, 93, 759–760. [Google Scholar]
  21. Perier N, Lebon W, Meyer L, Lekouch N, Aouiche N, Beugnet F. 2019. Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs. Parasite, 26, 63. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  22. Shoop WL, Hartline EJ, Gould BR, Waddell ME, McDowell RG, Kinney JB, Lahm GP, Long JK, Xu M, Wagerle T, Jones GS, Dietrich RF, Cordova D, Schroeder ME, Rhoades DF, Benner EA, Confalone PN. 2014. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. Veterinary Parasitology, 201, 179–189. [CrossRef] [PubMed] [Google Scholar]
  23. Zha C, Wang C, Sheele JM. 2017. Effect of moxidectin on bed bug feeding, development, fecundity, and survivorship. Insects, 8, 106. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.